Beximco Pharmaceuticals Limited (BXP.L)
GBp 36.5
(0.0%)
GBp 36.5
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 9.47 Billion BDT | -15.41% |
| 2021 | 11.2 Billion BDT | 61.04% |
| 2020 | 6.95 Billion BDT | -29.52% |
| 2019 | 9.86 Billion BDT | -23.34% |
| 2018 | 12.87 Billion BDT | 19.28% |
| 2017 | 10.79 Billion BDT | 150.06% |
| 2016 | 4.31 Billion BDT | -7.33% |
| 2015 | 4.65 Billion BDT | 3.58% |
| 2014 | 4.49 Billion BDT | 10.02% |
| 2013 | 4.08 Billion BDT | 31.5% |
| 2012 | 3.1 Billion BDT | -7.98% |
| 2011 | 3.37 Billion BDT | 39.59% |
| 2010 | 2.41 Billion BDT | -7.88% |
| 2009 | 2.62 Billion BDT | -24.58% |
| 2008 | 3.48 Billion BDT | 18.39% |
| 2007 | 2.94 Billion BDT | 13.44% |
| 2006 | 2.59 Billion BDT | -15.99% |
| 2005 | 3.08 Billion BDT | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 6.26 Billion BDT | -3.7% |
| 2023 Q1 | 7.41 Billion BDT | -21.75% |
| 2023 Q2 | 6.5 Billion BDT | -12.23% |
| 2022 Q2 | 10.25 Billion BDT | -7.91% |
| 2022 FY | 9.47 Billion BDT | -15.41% |
| 2022 Q4 | 9.47 Billion BDT | -8.95% |
| 2022 Q3 | 10.4 Billion BDT | 1.46% |
| 2022 Q1 | 11.13 Billion BDT | -0.57% |
| 2021 Q2 | 9.85 Billion BDT | -7.1% |
| 2021 Q3 | 11.24 Billion BDT | 14.06% |
| 2021 Q4 | 11.2 Billion BDT | -0.35% |
| 2021 FY | 11.2 Billion BDT | 61.04% |
| 2021 Q1 | 10.6 Billion BDT | 52.52% |
| 2020 Q4 | 6.95 Billion BDT | -12.79% |
| 2020 Q3 | 7.97 Billion BDT | -6.64% |
| 2020 Q2 | 8.54 Billion BDT | -7.17% |
| 2020 Q1 | 9.2 Billion BDT | -6.76% |
| 2020 FY | 6.95 Billion BDT | -29.52% |
| 2019 Q2 | 10.37 Billion BDT | -8.34% |
| 2019 Q1 | 11.31 Billion BDT | -12.11% |
| 2019 Q4 | 9.86 Billion BDT | -11.04% |
| 2019 Q3 | 11.09 Billion BDT | 6.96% |
| 2019 FY | 9.86 Billion BDT | -23.34% |
| 2018 Q2 | 10.87 Billion BDT | 1.5% |
| 2018 Q1 | 10.71 Billion BDT | -0.77% |
| 2018 Q4 | 12.87 Billion BDT | 20.93% |
| 2018 FY | 12.87 Billion BDT | 19.28% |
| 2018 Q3 | 10.64 Billion BDT | -2.07% |
| 2017 Q3 | 6.59 Billion BDT | 41.24% |
| 2017 Q2 | 4.66 Billion BDT | 14.14% |
| 2017 Q1 | 4.08 Billion BDT | -5.26% |
| 2017 FY | 10.79 Billion BDT | 150.06% |
| 2017 Q4 | 10.79 Billion BDT | 63.71% |
| 2016 Q4 | 4.31 Billion BDT | -1.68% |
| 2016 Q2 | 4.1 Billion BDT | 8.46% |
| 2016 Q3 | 4.39 Billion BDT | 6.95% |
| 2016 Q1 | 3.78 Billion BDT | -5.8% |
| 2016 FY | 4.31 Billion BDT | -7.33% |
| 2015 Q4 | 4.01 Billion BDT | 0.0% |
| 2015 Q1 | 4.84 Billion BDT | 1.62% |
| 2015 FY | 4.65 Billion BDT | 3.58% |
| 2015 Q2 | 4.49 Billion BDT | -7.07% |
| 2014 Q4 | 4.76 Billion BDT | 3.69% |
| 2014 Q3 | 4.59 Billion BDT | 2.19% |
| 2014 Q2 | 4.49 Billion BDT | -4.87% |
| 2014 Q1 | 4.72 Billion BDT | 5.57% |
| 2014 FY | 4.49 Billion BDT | 10.02% |
| 2013 Q1 | 2.72 Billion BDT | 4.01% |
| 2013 Q2 | 4.08 Billion BDT | 50.0% |
| 2013 Q3 | 4.52 Billion BDT | 10.81% |
| 2013 Q4 | 4.47 Billion BDT | -1.12% |
| 2013 FY | 4.08 Billion BDT | 31.5% |
| 2012 Q1 | 2.76 Billion BDT | 0.0% |
| 2012 Q3 | 3.08 Billion BDT | -0.67% |
| 2012 FY | 3.1 Billion BDT | -7.98% |
| 2012 Q4 | 2.61 Billion BDT | -15.15% |
| 2012 Q2 | 3.1 Billion BDT | 12.55% |
| 2011 Q2 | 3.37 Billion BDT | -10.2% |
| 2011 FY | 3.37 Billion BDT | 39.59% |
| 2011 Q1 | 3.76 Billion BDT | 60.18% |
| 2010 Q4 | 2.34 Billion BDT | -4.77% |
| 2010 Q1 | 2.45 Billion BDT | -0.39% |
| 2010 Q2 | 2.41 Billion BDT | -1.64% |
| 2010 Q3 | 2.46 Billion BDT | 1.9% |
| 2010 FY | 2.41 Billion BDT | -7.88% |
| 2009 Q1 | 4.1 Billion BDT | 12.08% |
| 2009 Q4 | 2.46 Billion BDT | 9.29% |
| 2009 Q3 | 2.25 Billion BDT | -13.97% |
| 2009 Q2 | 2.62 Billion BDT | -35.98% |
| 2009 FY | 2.62 Billion BDT | -24.58% |
| 2008 Q2 | 3.48 Billion BDT | 0.0% |
| 2008 Q4 | 3.66 Billion BDT | 0.0% |
| 2008 FY | 3.48 Billion BDT | 18.39% |
| 2007 Q2 | 2.94 Billion BDT | 0.0% |
| 2007 FY | 2.94 Billion BDT | 13.44% |
| 2007 Q4 | 3.11 Billion BDT | 0.0% |
| 2006 FY | 2.59 Billion BDT | -15.99% |
| 2005 FY | 3.08 Billion BDT | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|